|
ASX - By Stock
|
OCC |
Re:
Ann: US Market and Operational Update
|
|
Speckled
|
103 |
19K |
5 |
06/02/26 |
| 06/02/26 |
ASX - By Stock
|
103
|
19K
|
5
|
|
|
ASX - By Stock
|
OCC |
Re:
Ann: US Market and Operational Update
|
|
Speckled
|
103 |
19K |
8 |
05/02/26 |
| 05/02/26 |
ASX - By Stock
|
103
|
19K
|
8
|
|
|
ASX - By Stock
|
OCC |
Re:
Ann: US Market and Operational Update
|
|
Speckled
|
103 |
19K |
8 |
05/02/26 |
| 05/02/26 |
ASX - By Stock
|
103
|
19K
|
8
|
|
|
ASX - By Stock
|
OCC |
Re:
Ann: US Market and Operational Update
|
|
Speckled
|
103 |
19K |
3 |
05/02/26 |
| 05/02/26 |
ASX - By Stock
|
103
|
19K
|
3
|
|
|
ASX - By Stock
|
OCC |
Re:
Ann: US Market and Operational Update
|
|
Speckled
|
103 |
19K |
2 |
03/02/26 |
| 03/02/26 |
ASX - By Stock
|
103
|
19K
|
2
|
|
|
ASX - By Stock
|
OCC |
Re:
Media thread
|
|
Speckled
|
1.3K |
515K |
6 |
01/02/26 |
| 01/02/26 |
ASX - By Stock
|
1.3K
|
515K
|
6
|
|
|
ASX - By Stock
|
OCC |
Re:
Media thread
|
|
Speckled
|
1.3K |
515K |
6 |
31/01/26 |
| 31/01/26 |
ASX - By Stock
|
1.3K
|
515K
|
6
|
|
|
ASX - By Stock
|
OCC |
Re:
Media thread
|
|
Speckled
|
1.3K |
515K |
5 |
31/01/26 |
| 31/01/26 |
ASX - By Stock
|
1.3K
|
515K
|
5
|
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Orthocell Investor Webinar Details
|
|
Speckled
|
38 |
6.0K |
7 |
31/01/26 |
| 31/01/26 |
ASX - By Stock
|
38
|
6.0K
|
7
|
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Orthocell Investor Webinar Details
|
|
Speckled
|
38 |
6.0K |
8 |
30/01/26 |
| 30/01/26 |
ASX - By Stock
|
38
|
6.0K
|
8
|
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Orthocell Investor Webinar Details
|
|
Speckled
|
38 |
6.0K |
13 |
30/01/26 |
| 30/01/26 |
ASX - By Stock
|
38
|
6.0K
|
13
|
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Orthocell Investor Webinar Details
|
|
Speckled
|
38 |
6.0K |
9 |
30/01/26 |
| 30/01/26 |
ASX - By Stock
|
38
|
6.0K
|
9
|
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Orthocell Investor Webinar Details
|
|
Speckled
|
38 |
6.0K |
14 |
30/01/26 |
| 30/01/26 |
ASX - By Stock
|
38
|
6.0K
|
14
|
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Orthocell Investor Webinar Details
|
|
Speckled
|
38 |
6.0K |
4 |
30/01/26 |
| 30/01/26 |
ASX - By Stock
|
38
|
6.0K
|
4
|
|
|
ASX - By Stock
|
OCC |
Re:
Ann: First Commercial Sales of Remplir Achieved in Hong Kong
|
|
Speckled
|
161 |
23K |
7 |
29/01/26 |
| 29/01/26 |
ASX - By Stock
|
161
|
23K
|
7
|
|
|
ASX - By Stock
|
OCC |
Re:
OCC Trading
|
|
Speckled
|
2.8K |
996K |
6 |
29/01/26 |
| 29/01/26 |
ASX - By Stock
|
2.8K
|
996K
|
6
|
|
|
ASX - By Stock
|
OCC |
Re:
OCC chart
|
|
Speckled
|
2.8K |
1.3M |
3 |
28/01/26 |
| 28/01/26 |
ASX - By Stock
|
2.8K
|
1.3M
|
3
|
|
|
ASX - By Stock
|
OCC |
Re:
OCC chart
|
|
Speckled
|
2.8K |
1.3M |
10 |
28/01/26 |
| 28/01/26 |
ASX - By Stock
|
2.8K
|
1.3M
|
10
|
|
|
ASX - By Stock
|
OCC |
Re:
OCC chart
|
|
Speckled
|
2.8K |
1.3M |
8 |
28/01/26 |
| 28/01/26 |
ASX - By Stock
|
2.8K
|
1.3M
|
8
|
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Orthocell Finalises Strategic Investment in Marine Biomedica
|
|
Speckled
|
40 |
9.0K |
5 |
23/01/26 |
| 23/01/26 |
ASX - By Stock
|
40
|
9.0K
|
5
|
|
|
ASX - By Stock
|
OCC |
Re:
Orthocell Technology
|
|
Speckled
|
51 |
19K |
5 |
19/01/26 |
| 19/01/26 |
ASX - By Stock
|
51
|
19K
|
5
|
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Remplir gains momentum in nerve-sparing prostate surgery
|
|
Speckled
|
193 |
39K |
2 |
17/01/26 |
| 17/01/26 |
ASX - By Stock
|
193
|
39K
|
2
|
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Orthocell Finalises Strategic Investment in Marine Biomedica
|
|
Speckled
|
40 |
9.0K |
9 |
16/01/26 |
| 16/01/26 |
ASX - By Stock
|
40
|
9.0K
|
9
|
|
|
ASX - By Stock
|
OCC |
Re:
USA Revenue forecasts and SP Catalysts
|
|
Speckled
|
7 |
2.0K |
2 |
15/01/26 |
| 15/01/26 |
ASX - By Stock
|
7
|
2.0K
|
2
|
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Remplir gains momentum in nerve-sparing prostate surgery
|
|
Speckled
|
193 |
39K |
1 |
14/01/26 |
| 14/01/26 |
ASX - By Stock
|
193
|
39K
|
1
|
|
|
ASX - By Stock
|
OCC |
Re:
Remplir vs. Incumbents
|
|
Speckled
|
15 |
3.4K |
6 |
12/01/26 |
| 12/01/26 |
ASX - By Stock
|
15
|
3.4K
|
6
|
|
|
ASX - By Stock
|
OCC |
Re:
Remplir vs. Incumbents
|
|
Speckled
|
15 |
3.4K |
13 |
10/01/26 |
| 10/01/26 |
ASX - By Stock
|
15
|
3.4K
|
13
|
|
|
ASX - By Stock
|
OCC |
Re:
Remplir vs. Incumbents
|
|
Speckled
|
15 |
3.4K |
7 |
10/01/26 |
| 10/01/26 |
ASX - By Stock
|
15
|
3.4K
|
7
|
|
|
ASX - By Stock
|
OCC |
Re:
Remplir vs. Incumbents
|
|
Speckled
|
15 |
3.4K |
9 |
09/01/26 |
| 09/01/26 |
ASX - By Stock
|
15
|
3.4K
|
9
|
|
|
ASX - By Stock
|
OCC |
Re:
Media thread
|
|
Speckled
|
1.3K |
515K |
4 |
09/01/26 |
| 09/01/26 |
ASX - By Stock
|
1.3K
|
515K
|
4
|
|
|
ASX - By Stock
|
OCC |
Re:
Media thread
|
|
Speckled
|
1.3K |
515K |
4 |
09/01/26 |
| 09/01/26 |
ASX - By Stock
|
1.3K
|
515K
|
4
|
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Orthocell Posts Seventh Straight Record Revenue Quarter
|
|
Speckled
|
129 |
23K |
6 |
08/01/26 |
| 08/01/26 |
ASX - By Stock
|
129
|
23K
|
6
|
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Orthocell Posts Seventh Straight Record Revenue Quarter
|
|
Speckled
|
129 |
23K |
12 |
07/01/26 |
| 07/01/26 |
ASX - By Stock
|
129
|
23K
|
12
|
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Orthocell Posts Seventh Straight Record Revenue Quarter
|
|
Speckled
|
129 |
23K |
10 |
07/01/26 |
| 07/01/26 |
ASX - By Stock
|
129
|
23K
|
10
|
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Remplir Regulatory Application for US$750m EU-UK Market
|
|
Speckled
|
371 |
55K |
1 |
06/01/26 |
| 06/01/26 |
ASX - By Stock
|
371
|
55K
|
1
|
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Remplir Regulatory Application for US$750m EU-UK Market
|
|
Speckled
|
371 |
55K |
7 |
05/01/26 |
| 05/01/26 |
ASX - By Stock
|
371
|
55K
|
7
|
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Remplir Regulatory Application for US$750m EU-UK Market
|
|
Speckled
|
371 |
55K |
12 |
05/01/26 |
| 05/01/26 |
ASX - By Stock
|
371
|
55K
|
12
|
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Remplir Regulatory Application for US$750m EU-UK Market
|
|
Speckled
|
371 |
55K |
9 |
02/01/26 |
| 02/01/26 |
ASX - By Stock
|
371
|
55K
|
9
|
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Remplir Regulatory Application for US$750m EU-UK Market
|
|
Speckled
|
371 |
55K |
11 |
31/12/25 |
| 31/12/25 |
ASX - By Stock
|
371
|
55K
|
11
|
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Remplir Regulatory Application for US$750m EU-UK Market
|
|
Speckled
|
371 |
55K |
9 |
30/12/25 |
| 30/12/25 |
ASX - By Stock
|
371
|
55K
|
9
|
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Remplir Regulatory Application for US$750m EU-UK Market
|
|
Speckled
|
371 |
55K |
12 |
24/12/25 |
| 24/12/25 |
ASX - By Stock
|
371
|
55K
|
12
|
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Remplir Regulatory Application for US$750m EU-UK Market
|
|
Speckled
|
371 |
55K |
5 |
23/12/25 |
| 23/12/25 |
ASX - By Stock
|
371
|
55K
|
5
|
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Remplir Regulatory Application for US$750m EU-UK Market
|
|
Speckled
|
371 |
55K |
3 |
23/12/25 |
| 23/12/25 |
ASX - By Stock
|
371
|
55K
|
3
|
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Remplir Regulatory Application for US$750m EU-UK Market
|
|
Speckled
|
371 |
55K |
7 |
23/12/25 |
| 23/12/25 |
ASX - By Stock
|
371
|
55K
|
7
|
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Remplir Regulatory Application for US$750m EU-UK Market
|
|
Speckled
|
371 |
55K |
2 |
22/12/25 |
| 22/12/25 |
ASX - By Stock
|
371
|
55K
|
2
|
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Remplir Regulatory Application for US$750m EU-UK Market
|
|
Speckled
|
371 |
55K |
2 |
22/12/25 |
| 22/12/25 |
ASX - By Stock
|
371
|
55K
|
2
|
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Remplir Regulatory Application for US$750m EU-UK Market
|
|
Speckled
|
371 |
55K |
6 |
22/12/25 |
| 22/12/25 |
ASX - By Stock
|
371
|
55K
|
6
|
|
|
ASX - By Stock
|
OCC |
Re:
OCC Broker Data
|
|
Speckled
|
313 |
143K |
5 |
22/12/25 |
| 22/12/25 |
ASX - By Stock
|
313
|
143K
|
5
|
|
|
ASX - By Stock
|
OCC |
Re:
OCC Broker Data
|
|
Speckled
|
313 |
143K |
6 |
22/12/25 |
| 22/12/25 |
ASX - By Stock
|
313
|
143K
|
6
|
|
|
ASX - By Stock
|
OCC |
Re:
OCC Broker Data
|
|
Speckled
|
313 |
143K |
2 |
22/12/25 |
| 22/12/25 |
ASX - By Stock
|
313
|
143K
|
2
|
|